现在位置：百拇书刊 > 基础医学 > 抗菌试剂及化学方法 > 2003年.第1期 《抗菌试剂及化学方法》.2003年.第1期  * A Clonal Lineage of VanA-Type Enterococcus faecalis Predominates in Vancomycin-Resistant Enterococci Isolated in New Zealand  * A Type II Pathway for Fatty Acid Biosynthesis Presents Drug Targets in Plasmodium falciparum  * Activation and Deactivation of a Broad-Spectrum Antiviral Drug by a Single Enzyme: Adenosine Deaminase Catalyzes Two Consecutive Deamination Reactions  * Activities of HMR 3787 and RU 64399 Compared with Those of Four Other Agents against Haemophilus influenzae and Haemophilus parainfluenzae  * Activities of Moxifloxacin Alone and in Combination with Other Antimicrobial Agents against Multidrug-Resistant Mycobacterium tuberculosis Infection i  * Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial Isolates  * Activity and Diffusion of Tigecycline (GAR-936) in Experimental Enterococcal Endocarditis  * Antibiotic Susceptibilities of Anaplasma (Ehrlichia) phagocytophilum Strains from Various Geographic Areas in the United States  * Antimicrobial Susceptibilities of Campylobacter Strains Isolated from Finnish Subjects Infected Domestically or from Those Infected Abroad  * Chemotherapy with Benznidazole and Itraconazole for Mice Infected with Different Trypanosoma cruzi Clonal Genotypes  * Class 1 Integron-Borne Gene Cassettes in Multidrug-Resistant Yersinia enterocolitica Strains of Different Phenotypic and Genetic Types  * Clindamycin Modulates Inflammatory-Cytokine Induction in Lipopolysaccharide-Stimulated Mouse Peritoneal Macrophages  * Clinical Trichophyton rubrum Strain Exhibiting Primary Resistance to Terbinafine  * Combination of Drug Level Measurement and Parasite Genotyping Data for Improved Assessment of Amodiaquine and Sulfadoxine-Pyrimethamine Efficacies in  * Comparative Molecular Analysis of Community- or Hospital-Acquired Methicillin-Resistant Staphylococcus aureus  * Comparison of Anti-Hepatitis B Virus Activities of Lamivudine and Clevudine by a Quantitative Assay  * Comparison of Linezolid Activities under Aerobic and Anaerobic Conditions against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant  * Contribution of the 8-Methoxy Group to the Activity of Gatifloxacin against Type II Topoisomerases of Streptococcus pneumoniae  * Contributions of Antibiotic Penetration, Oxygen Limitation and Low Metabolic Activity to Tolerance of Pseudomonas aeruginosa Biofilms to Ciprofloxaci  * Contributions of MexAB-OprM and an EmrE Homolog to Intrinsic Resistance of Pseudomonas aeruginosa to Aminoglycosides and Dyes  * Correlation of Phenotypic Zidovudine Resistance with Mutational Patterns in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1: Interpre  * Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Pati  * Drug Targeting Mycobacterium tuberculosis Cell Wall Synthesis: Development of a Microtiter Plate-Based Screen for UDP-Galactopyranose Mutase and Ident  * Flow Cytometric Assessment of Susceptibilities of Streptococcus pyogenes to Erythromycin and Rokitamycin  * In34 a Complex In5 Family Class 1 Integron Containing orf513 and dfrA10  * In Vitro Activities of ABT-773 and Other Antimicrobials against Human Mycoplasmas  * In Vitro Activities of Cethromycin (ABT-773) a New Ketolide against Streptococcus pneumoniae Strains That Are Not Susceptible to Penicillin or Macro  * In Vitro Activities of Daptomycin Vancomycin Quinupristin- Dalfopristin Linezolid and Five Other Antimicrobials against 307 Gram-Positive Anaerobic  * In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis That Are Susceptible or Resistant to First-Line Antituberculo  * In Vitro Bactericidal Activities of Linezolid in Combination with Vancomycin Gentamicin Ciprofloxacin Fusidic Acid and Rifampin against Staphylococ  * In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against Clinical Scedosporium prolificans Isolates  * In Vitro Susceptibilities to and Bactericidal Activities of Garenoxacin (BMS-284756) and Other Antimicrobial Agents against Human Mycoplasmas and Urea  * In Vivo Antibacterial Activity of RWJ-54428 a New Cephalosporin with Activity against Gram-Positive Bacteria  * In Vivo Selection of Campylobacter Isolates with High Levels of Fluoroquinolone Resistance Associated with gyrA Mutations and the Function of the CmeA  * Integration of a Transposon Tn1-Encoded Inhibitor-Resistant ß-Lactamase Gene, blaTEM-67 from Proteus mirabilis, into the Escherichia coli Chromo  * Lincomycin Resistance Mutations in Two Regions Immediately Downstream of the -10 Region of lmr Promoter Cause Overexpression of a Putative Multidrug E  * Mannopeptimycins New Cyclic Glycopeptide Antibiotics Produced by Streptomyces hygroscopicus LL-AC98: Antibacterial and Mechanistic Activities  * Modeling of Transfer Kinetics at the Serum-Cerebrospinal Fluid Barrier in Rabbits with Experimental Meningitis: Application to Grepafloxacin  * Molecular Characterization of Quinolone-Resistant Neisseria gonorrhoeae in Hong Kong  * Moxifloxacin for Community-Acquired Pneumonia  * Mutant Prevention Concentration of Gemifloxacin for Clinical Isolates of Streptococcus pneumoniae  * Penetration of Dihydroartemisinin into Cerebrospinal Fluid after Administration of Intravenous Artesunate in Severe Falciparum Malaria  * Penetration of Fosfomycin into Inflammatory Lesions in Patients with Cellulitis or Diabetic Foot Syndrome  * pfcrt Polymorphism and Chloroquine Resistance in Plasmodium falciparum Strains Isolated in Cambodia  * Pharmacokinetic-Pharmacodynamic Analysis of Lopinavir-Ritonavir in Combination with Efavirenz and Two Nucleoside Reverse Transcriptase Inhibitors in E  * Population Pharmacokinetics and Pharmacodynamics of Efavirenz Nelfinavir and Indinavir: Adult AIDS Clinical Trial Group Study 398  * Reactivity of Reduced [2Fe-2S] Ferredoxins Parallels Host Susceptibility to Nitroimidazoles  * Regulation of Membrane Permeability by a Two-Component Regulatory System in Pseudomonas aeruginosa  * Ribonucleoside Analogue That Blocks Replication of Bovine Viral Diarrhea and Hepatitis C Viruses in Culture  * Ribavirin Quantification in Combination Treatment of Chronic Hepatitis C  * Roles of Mycobacterium smegmatis D-Alanine:D-Alanine Ligase and D-Alanine Racemase in the Mechanisms of Action of and Resistance to the Peptidoglycan  * Simple In Vitro Assay for Determining the Sensitivity of Plasmodium vivax Isolates from Fresh Human Blood to Antimalarials in Areas where P. vivax Is  * Activation and Deactivation of a Broad-Spectrum Antiviral Drug by a Single Enzyme: Adenosine Deaminase Catalyzes Two Consecutive Deamination Reactions  * Site-Specific Mutagenesis Analysis of PBP 1A from a Penicillin-Cephalosporin-Resistant Pneumococcal Isolate  * Steady-State Pharmacokinetics of Amprenavir Coadministered with Ritonavir in Human Immunodeficiency Virus Type 1-Infected Patients  * Structure-Activity Relationships for Inhibition of Cysteine Protease Activity and Development of Plasmodium falciparum by Peptidyl Vinyl Sulfones  * Susceptibility of Candida dubliniensis to Salivary Histatin 3  * Synergistic Activity of the N-Terminal Peptide of Human Lactoferrin and Fluconazole against Candida Species  * Synergistic Lethal Effect of a Combination of Phage Lytic Enzymes with Different Activities on Penicillin-Sensitive and -Resistant Streptococcus pneum  * The Proton Channel Is the Minimal Structure of ATP Synthase Necessary and Sufficient for Microcin H47 Antibiotic Action  * Topoisomerase Targeting with and Resistance to Gemifloxacin in Staphylococcus aureus  * Transcriptional Profile of the Escherichia coli Response to the Antimicrobial Insect Peptide Cecropin A  * Vancomycin Acts Synergistically with Gentamicin against Penicillin-Resistant Pneumococci by Increasing the Intracellular Penetration of Gentamicin  * VanD-Type Vancomycin-Resistant Enterococcus faecium 10/96A  * Worldwide Antimicrobial Susceptibility Patterns and Pharmacodynamic Comparisons of Gatifloxacin and Levofloxacin against Streptococcus pneumoniae: Rep